Immunosuppressive drugs and fertility
Conclusion: At the time of prescription, patients must be informed of the possible consequences of immunosuppressants on fertility and of the need for contraception. Pregnancy must be planned and the treatment modified if necessary in a pre-conception time period adapted to the half-life of the drug, imperatively in relation with the prescriber of the immunosuppressive drugs.
Source: Orphanet Journal of Rare Diseases - Category: Internal Medicine Authors: Clara LeroyJean-Marc RigotMaryse LeroyChristine DecanterKristell Le MapihanAnne-Sophie ParentAnne-Claire Le GuillouIbrahim Yakoub-AghaSébastien DharancyChristian NoelMarie-Christine Vantyghem Source Type: research
More News: Autoimmune Disease | Children | Copaxone | Gilenya | Internal Medicine | Methotrexate | Pregnancy | Prograf | Rare Diseases | Reproduction Medicine | Restasis | Tacrolimus | Transplants | Tysabri